Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC32H32N4O5 |
InChIKeyKLHOCHQJHXNKAS-UHFFFAOYSA-N |
CAS Registry1693731-40-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | GB | 22 Dec 2016 |